|
Pharmaceutical Executive
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 88 articles |
 Page 1 of 2 
|
Keryx.(Moving On + Up)
April 01, 2008
Laureate.(Moving On + Up)
April 01, 2008
Samaritan.(Moving On + Up)
April 01, 2008
PeriCor.(Moving On + Up)
April 01, 2008
Bristol-Myers Squibb.(Moving On + Up)
April 01, 2008
Immtech.(Moving On + Up)
April 01, 2008
Mylan.(Moving On + Up)
April 01, 2008
Eric K. Rowinsky.(Moving On + Up)
April 01, 2008
Genta.(Moving On + Up)
April 01, 2008
United BioSource.(Moving On + Up)
April 01, 2008
Boehringer Ingelheim received special certification from the National ...
April 01, 2008
Libby Wilson.(People)
April 01, 2008
Jacqueline Miller.(People)
April 01, 2008
On the pharm exec blog.(On the Web)
April 01, 2008
Analyzed in pharm exec direct.(On the Web)
April 01, 2008
New at pharmexec.com.(On the Web)
April 01, 2008
Correction.(Leading Indicators: News)(Correction notice)
April 01, 2008
Cogentus.(Moving On + Up)
April 01, 2008
Kamran Hosseini.(Moving On + Up)
April 01, 2008
Jill Buyon, Betty Diamond, Kenneth Kalunian, David Wofsy, and Debra Za...
April 01, 2008
Peter Covitz.(Moving On + Up)
April 01, 2008
Warren Jackman.(Moving On + Up)
April 01, 2008
Xenon.(Moving On + Up)
April 01, 2008
Wyeth.(Moving On + Up)
April 01, 2008
Memory.(Moving On + Up)
April 01, 2008
Mersana.(Moving On + Up)
April 01, 2008
Chakshu Research.(Moving On + Up)
April 01, 2008
MacuSight.(Moving On + Up)
April 01, 2008
ImmunoVaccine Technologies.(Moving On + Up)
April 01, 2008
Axial Biotech.(Moving On + Up)
April 01, 2008
Ambrx.(Moving On + Up)
April 01, 2008
Daniel Magilavy.(Moving On + Up)
April 01, 2008
Ardea.(Moving On + Up)
April 01, 2008
BioVascular.(Moving On + Up)
April 01, 2008
Aton.(Moving On + Up)
April 01, 2008
Nile.(Moving On + Up)
April 01, 2008
Proteolix.(Moving On + Up)
April 01, 2008
Tengion.(Moving On + Up)
April 01, 2008
Ocera.(Moving On + Up)
April 01, 2008
Onyx.(Moving On + Up)
April 01, 2008
Mike Fanfarillo has joined Molecular Profiles as operations director.(...
April 01, 2008
NPS.(Moving On + Up)
April 01, 2008
ViroPharma.(Moving On + Up)
April 01, 2008
Halozyme.(Moving On + Up)
April 01, 2008
Cadient.(People)
April 01, 2008
Kaelin Dezelan, Tommy Schenck, Donald Hanson, and Stacy Auer joined Ab...
April 01, 2008
Rapp Collins Worldwide.(People)
April 01, 2008
Sigma.(People)
April 01, 2008
Ketchum.(People)
April 01, 2008
Y Brand.(People)
April 01, 2008
inVentive Communications.(People)
April 01, 2008
Navicor.(People)
April 01, 2008
What they're saying ...(Leading Indicators: People + events + ideas th...
April 01, 2008
Listen up!(On the Web)(Public notice)
April 01, 2008
Tough TB on the rise: WHO reports highest rates of resistant tuberculo...
April 01, 2008
Congress eyes boost in Medicaid rebates: mental health parity reform i...
April 01, 2008
Top search terms: physician online research examined.(E-MEDIA)(Table)(...
April 01, 2008
Valuing diversity.(HIRE POWER: REGGIE SMITH)(Interview)
April 01, 2008
British biotech blues: can ceasing trade sales and finding funding hel...
April 01, 2008
Mind the (tax) gap: a little-known provision in a new law rewards empl...
April 01, 2008
On-the-job: off-label compliance: a user's guide to minimizing your co...
April 01, 2008
The navigator: HBA Woman of the Year: here's the saga of how market re...
April 01, 2008
2007 in M&A: 44 deals, $79 billion: the year in pharma and biotech fin...
April 01, 2008
GlaxoSmithKline gave $40,000 in unrestricted funds to each recipient o...
April 01, 2008
Money-back guarantee ... and other ways you never thought to sell your...
April 01, 2008
Putting your best face forward: meetings are the last area of unmanage...
April 01, 2008
They do things differently over there: meetings management without bor...
April 01, 2008
How safe are your meetings? Can you spot 12 risks--some physical, some...
April 01, 2008
Being pharma fluent: pharma meetings aren't like other meetings. Execu...
April 01, 2008
How to lose the e-snooze: e-meetings may be cost-effective, but let's ...
April 01, 2008
Molecular fraud: the real question in the Baxter heparin scandal is no...
April 01, 2008
Leading indicators: people + events + ideas that are shaping pharma's ...
April 01, 2008
Quotables.(Leading Indicators: News)(Brief article)
April 01, 2008
GSK's disclosure debacle: Seroxat investigation closed with no prosecu...
April 01, 2008
Congress proposes reporting of gifts to docs: Medicare weighs national...
April 01, 2008
More
articles from Pharmaceutical Executive...
|